Quest Diagnostics Incorporated (DGX)
Automate Your Wheel Strategy on DGX
With Tiblio's Option Bot, you can configure your own wheel strategy including DGX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol DGX
- Rev/Share 99.4144
- Book/Share 65.6396
- PB 3.2113
- Debt/Equity 0.965
- CurrentRatio 1.0439
- ROIC 0.0821
- MktCap 23075002527.0
- FreeCF/Share 12.2432
- PFCF 16.9794
- PE 23.2104
- Debt/Assets 0.4264
- DivYield 0.0154
- ROE 0.1388
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | DGX | Barclays | Equal Weight | Overweight | -- | $210 | Jan. 30, 2026 |
| Downgrade | DGX | Robert W. Baird | Outperform | Neutral | -- | $194 | Aug. 25, 2025 |
| Initiation | DGX | Redburn Atlantic | -- | Buy | -- | $195 | April 2, 2025 |
| Downgrade | DGX | Citigroup | Buy | Neutral | -- | $185 | March 4, 2025 |
| Upgrade | DGX | Leerink Partners | Market Perform | Outperform | $169 | $174 | Jan. 6, 2025 |
| Upgrade | DGX | Morgan Stanley | Equal Weight | Overweight | $145 | $172 | Dec. 17, 2024 |
| Resumed | DGX | Jefferies | -- | Buy | $175 | $185 | Dec. 10, 2024 |
| Upgrade | DGX | Robert W. Baird | Neutral | Outperform | $157 | $182 | Oct. 23, 2024 |
| Resumed | DGX | Evercore ISI | -- | In-line | -- | $165 | Aug. 28, 2024 |
News
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
Published: February 24, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue?
Published: February 11, 2026 by: Zacks Investment Research
Sentiment: Positive
Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
Quest Diagnostics Incorporated (DGX) Q4 2025 Earnings Call Transcript
Published: February 10, 2026 by: Seeking Alpha
Sentiment: Neutral
Quest Diagnostics Incorporated (DGX) Q4 2025 Earnings Call Transcript
Read More
Quest Diagnostics' Q4 Earnings & Revenues Beat Estimates, Stock Up
Published: February 10, 2026 by: Zacks Investment Research
Sentiment: Positive
DGX tops Q4 EPS and revenue estimates as volumes rise, shares jump premarket, and 2026 guidance points to steady growth.
Read More
Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock
Published: February 10, 2026 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Quest Diagnostics (DGX) Beats Q4 Earnings and Revenue Estimates
Published: February 10, 2026 by: Zacks Investment Research
Sentiment: Positive
Quest Diagnostics (DGX) came out with quarterly earnings of $2.42 per share, beating the Zacks Consensus Estimate of $2.35 per share. This compares to earnings of $2.23 per share a year ago.
Read More
Here's How Quest Diagnostics Is Placed Ahead of Q4 Earnings
Published: February 06, 2026 by: Zacks Investment Research
Sentiment: Positive
DGX heads into Q4 earnings with expected revenue and EPS growth, DIS momentum, and benefits from Fresenius assets and consumer testing.
Read More
Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term
Published: February 06, 2026 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
Published: February 05, 2026 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year
Published: January 21, 2026 by: PRNewsWire
Sentiment: Neutral
SECAUCUS, N.J., Jan. 21, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it has been named to the Fortune® magazine 2026 World's Most Admired Companies™ list, for the 12th consecutive year.
Read More
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term
Published: January 12, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026
Published: January 08, 2026 by: PRNewsWire
Sentiment: Neutral
SECAUCUS, N.J., Jan. 8, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that it will report fourth quarter and full year 2025 financial results on Tuesday, February 10, 2026, before the market opens.
Read More
Quest Diagnostics (DGX) is a Top-Ranked Growth Stock: Should You Buy?
Published: January 07, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Quest Diagnostics (DGX) Upgraded to Buy: Here's Why
Published: December 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year?
Published: December 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Here is how Quest Diagnostics (DGX) and Elicio Therapeutics (ELTX) have performed compared to their sector so far this year.
Read More
Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference
Published: December 19, 2025 by: PRNewsWire
Sentiment: Neutral
SECAUCUS, N.J. , Dec. 19, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading national provider of diagnostic information services, announced that Jim Davis, Chairman, CEO and President, and Sam Samad, Executive Vice President and Chief Financial Officer, will speak on the company's strategy, performance, and the latest market developments and trends during a presentation and Q&A session at the 44th Annual J.P.
Read More
Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock
Published: December 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Digi Power X Inc. (DGX:CA) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript
Published: December 09, 2025 by: Seeking Alpha
Sentiment: Neutral
Digi Power X Inc. (DGX:CA) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript
Read More
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
Published: December 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet?
Published: November 27, 2025 by: Zacks Investment Research
Sentiment: Positive
DGX's strong YTD gains and momentum in advanced diagnostics and acquisitions highlight why it may stand out in the competitive testing market against HOLX.
Read More
Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term
Published: November 26, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Quest Diagnostics (DGX) Up 2.6% Since Last Earnings Report: Can It Continue?
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock?
Read More
Quest Diagnostics Incorporated (DGX) Presents at 7th Annual Healthcare Symposium Transcript
Published: November 14, 2025 by: Seeking Alpha
Sentiment: Neutral
Quest Diagnostics Incorporated ( DGX ) 7th Annual Healthcare Symposium November 14, 2025 8:50 AM EST Company Participants Asia Chang Conference Call Participants Kevin Dreyer - GAMCO Investors, Inc. Carri Chan David Harding Noam Krantz - Guardant Health, Inc. Alexis Tosti Presentation Kevin Dreyer GAMCO Investors, Inc. Okay. I want to welcome everyone to our 7th Annual Healthcare Symposium jointly sponsored by Gabelli Funds and Columbia Business School.
Read More
Digi Power X Inc. (DGX:CA) Q3 2025 Earnings Call Transcript
Published: November 14, 2025 by: Seeking Alpha
Sentiment: Neutral
Digi Power X Inc. ( DGX:CA ) Q3 2025 Earnings Call November 14, 2025 8:30 AM EST Company Participants Michel Amar - Chairman & CEO Presentation Operator Good morning, and welcome to Digi Power X Inc.'s Third Quarter 2025 Financial Results Conference Call. Please note that this event is being recorded, and a transcript will be available on Digi Power X Inc.'s website.
Read More
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
Published: November 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Daily Dividend Report: ADP, Agree Realty, Group 1, DGX, Aflac
Published: November 12, 2025 by: Forbes
Sentiment: Positive
The board of directors of ADP approved a $0.16 increase in the quarterly cash dividend to an annual rate of $6.80 per share, Maria Black, ADP's President and Chief Executive Officer, announced today. The increased cash dividend marks the 51st consecutive year in which ADP, a leading global technology company providing human capital management solutions, has raised its quarterly dividend.
Read More
Quest Diagnostics (DGX) is a Top-Ranked Growth Stock: Should You Buy?
Published: November 10, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term
Published: October 27, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Quest Diagnostics: Strong Q3, Steady (Not Spectacular) Growth Ahead
Published: October 22, 2025 by: Seeking Alpha
Sentiment: Positive
Quest Diagnostics Incorporated announced its Q3 earnings yesterday - revenues year-to-date are $8.23bn, and net income $845m. DGX is finally demonstrating a strong post-pandemic recovery, with Q3 revenues up 13% and ambitious growth initiatives in advanced diagnostics and strategic partnerships. DGX's diverse client base, operational improvements, and recent acquisitions position it for steady, double-digit top and bottom-line growth over the next several years.
Read More
Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
About Quest Diagnostics Incorporated (DGX)
- IPO Date 1996-12-17
- Website https://www.questdiagnostics.com
- Industry Medical - Diagnostics & Research
- CEO James E. Davis
- Employees 55000